Tandem Diabetes Care Company Profile (NASDAQ:TNDM)

About Tandem Diabetes Care (TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TNDM
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $1.55
  • 50 Day Moving Average: $2.27
  • 200 Day Moving Average: $3.77
  • 52-Week Range: $1.52 - $11.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.11
  • P/E Growth: -0.03
  • Market Cap: $48.57M
  • Outstanding Shares: 31,335,000
  • Beta: 0.5
Profitability:
  • Net Margins: -95.57%
  • Return on Equity: -220.14%
  • Return on Assets: -72.51%
Debt:
  • Debt-to-Equity Ratio: 8.61%
  • Current Ratio: 2.04%
  • Quick Ratio: 1.38%

Analyst Ratings

Consensus Ratings for Tandem Diabetes Care (NASDAQ:TNDM) (?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $7.42 (378.49% upside)

Analysts' Ratings History for Tandem Diabetes Care (NASDAQ:TNDM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
3/11/2017B. RileyReiterated RatingBuy$5.00N/AView Rating Details
1/24/2017WedbushReiterated RatingPositiveN/AView Rating Details
11/3/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
11/2/2016Deutsche Bank AGLower Price TargetBuy$14.00 -> $9.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
11/2/2016Robert W. BairdDowngradeOutperform -> Neutral$11.00 -> $4.00N/AView Rating Details
11/2/2016Stifel NicolausDowngradeBuy -> Hold$15.00 -> $3.50N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
3/24/2016Bank of America CorpDowngradeNeutral -> UnderperformN/AView Rating Details
1/7/2016Cowen and CompanyBoost Price Target$15.00N/AView Rating Details
10/21/2015William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 3/22/2015 forward)

Earnings

Earnings History for Tandem Diabetes Care (NASDAQ:TNDM)
Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Earnings History by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017        
3/8/2017Q4 2016($0.65)($0.48)$22.75 million$24.80 millionViewListenView Earnings Details
7/28/2016Q216($0.65)($0.60)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($0.69)($0.68)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($0.51)($0.40)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($0.80)($0.65)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($0.71)($0.65)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($0.79)($0.83)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($0.81)($0.78)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($0.82)($0.85)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($0.91)($0.83)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($0.69)($0.96)$8.24 million$8.10 millionViewN/AView Earnings Details
11/8/2011$0.25$0.18ViewN/AView Earnings Details
8/9/2011$0.26$0.20ViewN/AView Earnings Details
5/10/2011$0.24$0.24ViewN/AView Earnings Details
3/14/2011$0.29$0.18ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tandem Diabetes Care (NASDAQ:TNDM)
Current Year EPS Consensus Estimate: $-1.88 EPS
Next Year EPS Consensus Estimate: $-1.40 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.71)($0.68)($0.69)
Q2 20164($0.65)($0.62)($0.63)
Q3 20164($0.60)($0.52)($0.55)
Q4 20165($0.70)($0.36)($0.54)
Q1 20174($0.71)($0.62)($0.68)
Q2 20173($0.63)($0.37)($0.46)
Q3 20173($0.50)($0.33)($0.39)
Q4 20174($0.28)($0.21)($0.25)
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Ownership Percentage: 37.10%
Institutional Ownership Percentage: 56.79%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.00View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.00View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.00View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.00View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.00View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.00View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.00View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Tandem Diabetes Care (NASDAQ:TNDM)
Latest Headlines for Tandem Diabetes Care (NASDAQ:TNDM)
Source:
DateHeadline
reuters.com logoBRIEF-Tandem Diabetes Care says offering 18 mln shares of common stock (NASDAQ:TNDM)
www.reuters.com - March 21 at 9:53 AM
News IconZacks Investment Research Lowers Tandem Diabetes Care Inc (TNDM) to Hold (NASDAQ:TNDM)
www.americanbankingnews.com - March 21 at 7:40 AM
finance.yahoo.com logoTANDEM DIABETES CARE INC Financials (NASDAQ:TNDM)
finance.yahoo.com - March 14 at 7:47 PM
News IconTandem Diabetes Care Inc (TNDM) Upgraded by Zacks Investment Research to “Buy” (NASDAQ:TNDM)
www.americanbankingnews.com - March 14 at 7:36 PM
benzinga.com logo18 Biggest Mid-Day Losers For Thursday | Benzinga - Benzinga (NASDAQ:TNDM)
www.benzinga.com - March 11 at 7:20 AM
News IconBRIEF-Tandem Diabetes Care qtrly loss per share $0.48 (NASDAQ:TNDM)
www.businessinsider.com - March 9 at 8:14 PM
finance.yahoo.com logoEdited Transcript of TNDM earnings conference call or presentation 8-Mar-17 9:30pm GMT (NASDAQ:TNDM)
finance.yahoo.com - March 9 at 8:13 PM
reuters.com logoBRIEF-Tandem Diabetes to implement infusion set connector for tandem insulin pump cartridges and infusion sets (NASDAQ:TNDM)
www.reuters.com - March 9 at 4:07 AM
seekingalpha.com logoTandem Diabetes Care's (TNDM) CEO Kim Blickenstaff on Q4 2016 Results - Earnings Call Transcript (NASDAQ:TNDM)
seekingalpha.com - March 9 at 4:07 AM
biz.yahoo.com logoQ4 2016 Tandem Diabetes Care Inc Earnings Release - After Market Close (NASDAQ:TNDM)
us.rd.yahoo.com - March 8 at 11:06 PM
us.rd.yahoo.com logoTandem Diabetes Care Announces Plans for Improved Infusion Set Connector Developed from Customer Feedback (NASDAQ:TNDM)
us.rd.yahoo.com - March 8 at 11:06 PM
us.rd.yahoo.com logoTandem Diabetes Care Reports 2016 Financial Results (NASDAQ:TNDM)
us.rd.yahoo.com - March 8 at 11:06 PM
us.rd.yahoo.com logo4:08 pm Tandem Diabetes Care beats by $0.15, beats on revs; guides FY17 revs in-line (NASDAQ:TNDM)
us.rd.yahoo.com - March 8 at 11:06 PM
biz.yahoo.com logoTANDEM DIABETES CARE INC Files SEC form 10-K, Annual Report (NASDAQ:TNDM)
us.rd.yahoo.com - March 8 at 11:06 PM
biz.yahoo.com logoTANDEM DIABETES CARE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fi (NASDAQ:TNDM)
us.rd.yahoo.com - March 8 at 11:06 PM
finance.yahoo.com logoTandem Diabetes Care Announces Filing of Registration Statement for Proposed Follow-on Public Offering of Common Stock (NASDAQ:TNDM)
finance.yahoo.com - March 8 at 11:06 PM
finance.yahoo.com logoTandem Diabetes Care Launches First Ever Remote Software Update for Insulin Pump using a Personal Computer (NASDAQ:TNDM)
finance.yahoo.com - March 2 at 9:17 AM
finance.yahoo.com logoTandem Diabetes Care Schedules Fourth Quarter and Full Year 2016 Earnings Press Release and Conference Call (NASDAQ:TNDM)
finance.yahoo.com - February 21 at 4:42 PM
uk.finance.yahoo.com logoData Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump (SAP) over Medtronic MiniMed SAPs (NASDAQ:TNDM)
uk.finance.yahoo.com - February 16 at 8:06 PM
finance.yahoo.com logo1:02 pm Tandem Diabetes Care present study results comparing retrospective user data from its sensor-augmented pumps vs Medtronic (MDT (NASDAQ:TNDM)
finance.yahoo.com - February 16 at 8:06 PM
seekingalpha.com logoNIH Trials Set Up Artificial Pancreas Market Battle (NASDAQ:TNDM)
seekingalpha.com - February 11 at 5:38 AM
biz.yahoo.com logoTANDEM DIABETES CARE INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TNDM)
biz.yahoo.com - February 8 at 8:00 AM

Social

Frequently Asked Questions for Tandem Diabetes Care (NASDAQ:TNDM)

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care Inc (NASDAQ:TNDM) released its earnings results on Wednesday, March, 8th. The company reported ($0.48) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.65) by $0.17. The firm earned $24.80 million during the quarter, compared to analyst estimates of $22.75 million. Tandem Diabetes Care had a negative net margin of 95.57% and a negative return on equity of 220.14%. The business's revenue was down 14.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.40) EPS.

When will Tandem Diabetes Care make its next earnings announcement?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2017?

10 equities research analysts have issued 12-month price objectives for Tandem Diabetes Care's shares. Their predictions range from $3.50 to $12.00. On average, they expect Tandem Diabetes Care's stock price to reach $7.42 in the next twelve months.

Who owns Tandem Diabetes Care stock?

Tandem Diabetes Care's stock is owned by a number of of retail and institutional investors. Top institutional investors include Frontier Capital Management Co. LLC (3.57%), Renaissance Technologies LLC (0.99%), Eventide Asset Management LLC (0.90%), State Street Corp (0.76%), Keybank National Association OH (0.23%) and Wrapmanager Inc. (0.20%). Company insiders that own Tandem Diabetes Care stock include Dick Allen and John F Sheridan.

Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Frontier Capital Management Co. LLC.

Who bought Tandem Diabetes Care stock? Who is buying Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was bought by a variety of institutional investors in the last quarter, including A.R.T. Advisors LLC, First Republic Investment Management Inc., Wrapmanager Inc., Keybank National Association OH and State Street Corp.

How do I buy Tandem Diabetes Care stock?

Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Tandem Diabetes Care stock cost?

One share of Tandem Diabetes Care stock can currently be purchased for approximately $1.55.

Tandem Diabetes Care (TNDM) Chart for Wednesday, March, 22, 2017

This page was last updated on 3/22/2017 by MarketBeat.com Staff